Security reports

Bruker manufactures scientific instruments and analytical solutions for life science research, materials analysis, and diagnostics. The company provides technologies including mass spectrometry, nuclear magnetic resonance, microscopy, X-ray fluorescence, and infrared spectroscopy systems for laboratory and industrial applications.

Benitec Biopharma is a biopharmaceutical company that develops gene therapies using DNA-directed RNA interference (ddRNAi) technology for gene silencing. The company focuses on treatments for chronic and life-threatening genetic conditions that currently lack effective cures.

Agios is a biopharmaceutical company focused on developing therapies for rare diseases through its expertise in cellular metabolism. The company specializes in treatments for hemolytic and acquired anemias, including conditions such as pyruvate kinase deficiency, sickle cell disease, and thalassemia.

Amphastar Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets injectable, intranasal, and inhalation products. The company produces complex medications including biologics, biosimilars, and proprietary drug delivery systems for various therapeutic applications.

Allergan plc is a pharmaceutical company that develops, manufactures, and markets branded pharmaceutical, biologic, surgical, and regenerative medicine products. The company operates through several therapeutic categories including eye care, neurosciences, medical aesthetics, and gastroenterology.

Eli Lilly and Company is a pharmaceutical corporation that discovers, develops, manufactures, and markets prescription medications for human and animal health. The company produces treatments across multiple therapeutic areas including diabetes, oncology, immunology, and neuroscience.

Medtronic manufactures medical devices and therapies for chronic diseases, including cardiac rhythm management systems, surgical technologies, diabetes management products, and neurological devices. The company develops and distributes healthcare solutions across multiple therapeutic areas for hospitals, physicians, and patients globally.

Illumina develops and manufactures sequencing and microarray systems for genetic analysis and molecular diagnostics. The company provides next-generation sequencing platforms, library preparation kits, and bioinformatics software for research and clinical applications in genomics.

Agenus is a biopharmaceutical company that develops cancer immunotherapies designed to activate the immune system to recognize and eliminate tumors. The company's primary drug candidates include botensilimab and balstilimab, which are being tested in clinical trials for various cancer types including colorectal cancer, ovarian cancer, and sarcomas.

Thermo Fisher Scientific manufactures and distributes scientific instruments, laboratory equipment, reagents, consumables, and software for research, analysis, discovery, and diagnostics. The company serves pharmaceutical, biotechnology, academic, government, and industrial laboratories.

Compugen provides IT infrastructure solutions and services to enterprise and public sector clients. The company offers hardware, software, cloud services, and managed IT solutions across various technology platforms. It operates as a technology solutions provider focused on digital transformation and infrastructure modernization.

Arbutus Biopharma is a biotechnology company focused on developing antiviral therapeutics for chronic hepatitis B virus (HBV) infection. The company's pipeline includes RNAi therapeutics and other drug candidates designed to suppress viral replication, reduce viral antigens, and boost immune response through combination therapy approaches.

CohBar is a biotechnology company focused on the research and development of mitochondria-based therapeutics. The company develops peptide drugs derived from mitochondrial DNA to treat diseases associated with aging, including metabolic disorders and cardiovascular conditions.

Incyte is a biopharmaceutical company that discovers, develops, and commercializes medicines across three therapeutic areas: hematology, oncology, and inflammation and autoimmunity. The company maintains a clinical pipeline and markets approved treatments for various medical conditions.

China Biologic Products is a biopharmaceutical company that manufactures plasma-based products and biological medications. The company's core business includes the research, development, production, and distribution of blood plasma derivatives such as human serum albumin, human immunoglobulin, and coagulation factors.

Intuitive Surgical develops and manufactures robotic-assisted surgical systems for minimally invasive procedures. The company's primary product is the da Vinci Surgical System, which enables surgeons to perform complex operations through small incisions using robotic technology.

argenx is a biotechnology company that develops antibody-based therapies for severe autoimmune diseases. The company's products include VYVGART and VYVGART Hytrulo, approved treatments for conditions such as generalized myasthenia gravis and chronic inflammatory demyelinating polyneuropathy.

Bristol-Myers Squibb is a global biopharmaceutical company that discovers, develops, and manufactures prescription medicines for patients with serious diseases. The company focuses on therapeutic areas including oncology, cardiovascular disease, immunology, and fibrosis.

BASi develops and manufactures automated sampling systems and scientific instruments for preclinical research. The company's products include the Culex automated blood collection systems, open flow microperfusion equipment, and electrochemistry tools used in laboratory animal studies.

Alimera Sciences is a pharmaceutical company that specializes in ophthalmic products for the treatment of retinal diseases. The company develops and commercializes prescription therapeutics through a network of distribution partners.

Avadel Pharmaceuticals plc is a biopharmaceutical company focused on developing and commercializing treatments for narcolepsy. The company applies drug delivery technologies to create medications that address challenges patients experience with existing therapeutic options.

Adial Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapies for the treatment and prevention of addiction and related disorders. The company's lead drug candidate, AD04, is a genetically targeted serotonin-3 receptor antagonist being investigated for alcohol use disorder in patients with specific genotypes identified through a proprietary companion diagnostic test.

Nektar Therapeutics is a biopharmaceutical company that develops medicines for autoimmune and inflammatory conditions. The company focuses on therapies designed to resolve immune imbalances and restore immune homeostasis through its pipeline of therapeutic candidates.

Builders FirstSource supplies structural building products, value-added components, and installation services to professional contractors in the residential construction and remodeling markets. The company operates through a network of distribution facilities and manufacturing centers that produce pre-cut framing packages, trusses, and millwork.

Amgen discovers, develops, manufactures, and delivers biologic medicines using living cells to treat serious illnesses. The company focuses on therapeutic areas with limited treatment options, producing human therapeutics for patients with conditions including cardiovascular disease, cancer, and autoimmune disorders.

Array BioPharma is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted small molecule drugs to treat patients with cancer and other diseases. The company develops therapies designed to regulate specific biological pathways implicated in disease.

Cyclacel Pharmaceuticals is a biopharmaceutical company focused on developing therapies for cancer and other proliferative diseases. The company's pipeline includes small molecule drugs that target cell cycle and transcriptional regulation pathways.

Aerie Pharmaceuticals was a biopharmaceutical company focused on the discovery, development, and commercialization of ophthalmic pharmaceutical therapies for diseases of the eye. The company developed products for glaucoma treatment, including Rhopressa and Rocklatan. Aerie was acquired by Alcon in November 2022.

Exelixis is a biotechnology company focused on the discovery, development, and commercialization of cancer treatments. The company advances oncology therapies through multiple modalities including small molecule drugs, bispecific antibodies, and antibody-drug conjugates.

Acorda Therapeutics is a biopharmaceutical company that develops and commercializes therapies for neurological disorders. The company focuses on treatments for conditions such as multiple sclerosis and other central nervous system diseases.

Eurofins provides laboratory testing and analytical services across multiple sectors including food, pharmaceuticals, environmental science, agriculture, and consumer products. The company operates a network of laboratories offering analytical methods for product testing, contract research, clinical diagnostics, and forensic services.

Akorn is a pharmaceutical company that specializes in the development, manufacturing, and marketing of generic and branded prescription pharmaceuticals, as well as over-the-counter products. The company focuses on ophthalmic, injectable, and other specialized drug formulations.

Biogen is a biotechnology company that develops and manufactures therapies for neurological, immunological, and rare diseases. The company focuses on treatments for conditions such as multiple sclerosis, spinal muscular atrophy, and Alzheimer's disease.

ChromaDex develops and commercializes NAD+ precursor ingredients and supplements for cellular health and aging support. The company conducts clinical research on nicotinamide riboside (NR) and markets products under brands including Tru Niagen.

Checkpoint Therapeutics was a biopharmaceutical company focused on developing therapeutic antibodies and targeted small molecule inhibitors for oncology treatment. The company maintained a pipeline of drug candidates in various stages of clinical development before being acquired by Sun Pharma in 2025.

Catalent operates as a contract development and manufacturing organization (CDMO) that provides drug development, manufacturing, and delivery services for pharmaceutical, biotech, and self-care companies. The company offers solutions across oral dose forms, biologics, specialty products, clinical supply, and consumer health products including over-the-counter medications and dietary supplements.

Caladrius Biosciences is a clinical-stage biopharmaceutical company focused on developing cell-based therapies for select cardiovascular and autoimmune diseases. The company's product candidates utilize CD34+ cell technology to address conditions with significant unmet medical needs.

Biohaven Pharmaceuticals is a biopharmaceutical company focused on discovering, developing, and commercializing treatments for neurological, neuropsychiatric, immunological, and oncological diseases. The company operates multiple drug development platforms and maintains a pipeline of late-stage and early-stage therapeutic programs addressing conditions with significant unmet medical needs.

Arena Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing therapeutic treatments for various medical conditions. The company conducts research and clinical trials to advance drug candidates targeting immune-inflammatory and cardiovascular diseases.

BioLineRx is a biopharmaceutical company that develops therapeutic treatments for oncology and rare diseases. The company provides drug development services spanning from early-stage research through clinical trials to regulatory approval.